Jesús Gibran Hernández-Pérez

10PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNutritional epidemiologyBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 12, 2026
Comparative risk of hepatocellular carcinoma and mortality among initiators of GLP-1 receptor agonists versus other glucose-lowering therapies: a target trial emulation.

|May 05, 2026
Cardiovascular Disease and Obesity Medications in Older Women by Obesity-Related Cancers Status: SEER-Medicare 2007-2015.

|Mar 19, 2026
GLP-1 RAs and Kidney Cancer Risk: Methodological Considerations in Active-Comparator Selection.

David S Lopez, Omer Abdelgadir, Jesús Gibran Hernández-Pérez

|Sep 27, 2025
Obesity-Related Cancers in Relation to Use of Statins and Testosterone Replacement Therapy Among Older Women: SEER-Medicare 2007-2015.

Maryam R Hussain, Shannon Wu, Diane Saab

|Sep 03, 2025
Antioxidant and pro-oxidant dietary consumption patterns and their association with prostate cancer: a case-control study from Mexico City.

Angélica Martínez-Alonso, Jesús Gibran Hernández-Pérez, Marcia Galván-Portillo

|Apr 16, 2025
Personal care products exposure patterns and prostate cancer: evidence from a case-control study in Mexico City.

Luisa Torres-Sánchez, Jesús Gibran Hernández-Pérez, David S Lopez

Pageof 2

Frequent Collaborators

6 joint publications

David S López

6 joint publications

Luisa Torres-Sánchez

3 joint publications

Ruth Argelia Vázquez-Salas

2 joint publications

Jaime P Almandoz